FDA Approves Use Of Nexium(R) In Children Ages 12 To 17 For Short-Term Treatment Of GERD

... AstraZeneca (NYSE:AZN) announced today that the U.S. Food and Drug Administration (FDA) hasapproved the use of NEXIUM(R) (esomeprazole magnesium) delayed releasecapsules, in children ages 12 to 17 for the short-term treatment ofgastroesophageal reflux disease (GERD). "GERD isn't just a disease that affects adults, it also is common inchildhood and can be problematic for adolescents as well," said MartaIllueca, MD, F... click link for more info. ...